Catch the Rising Stars of Medical Technology in Paris, France, at the Upcoming Investment-In-Innovation (In3) Europe Conference, April 29-30, 2009, Paris, France.IRVINE, Calif. -- Medtech Insight, a division of Windhover Conferences, is hosting its 35th "Investment In Innovation (In3) Europe" conference, being held April 29-30, 2009, at The Marriott Rive Gauche Hotel in Paris, France. The conference is a do-not-miss worldwide med device event for those looking to partner, invest and network with the most promising medical technology companies. Presenting companies to date (with many presenting at an In3 event for the first time) include: BBS (1) (Bulletin Board System) A computer system used as an information source and forum for a particular interest group. They were widely used in the U.S. Bioactive Bone Substitutes; Cardio Biosciences SA; Cardiola, Ltd.; Facet Solutions; Invendo Medical GmbH; Lifenova Biomedical SA; Medical Device Works; mNemoScience GmbH; MTM MTM Medication Therapy Management MTM Minutes to Midnight (Linkin Park album) MTM Mary Tyler Moore (actress) MTM Made to Measure MTM Motoren-Technik-Mayer MTM Methods Time Measurement Laboratories; Nanobiotix; NOLabs AB; Photo Dynamic Therapy; PolyMedix, Inc.; Quanta Fluid Solutions; Sensile Medical AG; Sensimed AG; Symetis SA; ThermopeutiX, Inc.; Vittamed; and Vivostat A/B A/B Airborne A/B Afterburner (jet engines) A/B Air Blast A/B Answerback A/B Auto-brake A/B Air Bus A/B Afterburning , among many others being added to the program regularly. A presenting company product exhibition and networking reception will take place on Wednesday evening, April 29th. Companies in attendance include: 7 Health Ventures, Abbott Laboratories, Abingworth Management Ltd., Bard Ltd., Boston Scientific EarlyBird Ventures, Edmond de Rothschild Investment Partners, Edwards Lifesciences Corporation, Kimberly-Clark Health Care, FCPR FCPR Fonds Communs de Placement à Risques (French: Venture Capital Fund) FCPR Florida Center for Prevention Research (Florida State University) , Medtronic Europe, Novartis Pharmsa AG, Sarl, Paul Capital Partners, Pitango Venture Capital, Rothschild Gestion-Paris, Sanofi-Aventis Deutschland GmbH, Sofinnova Partners. A panel discussion titled "Trends in European Dealmaking and Investing" showcases several investors that provide unconventional wisdom on the issues faced by today's medical device players, big and small - from identifying hot clinical areas to understanding the changing funding environment to assessing the current state of M&A and IPOs, as well as looking at market adoption trends and evolving device business models in Europe. Panelists include Antoine Papiernik, Managing Partner, Sofinnova Partners; Dr. Thierry Chignon chi·gnon n. A roll or knot of hair worn at the back of the head or especially at the nape of the neck. [French, from Old French chaignon, chain, collar, nape, from Vulgar Latin , Partner, Matignon Investissement & Gestic ges·tic adj. Relating to bodily movements or gestures, especially in dancing. [From obsolete gest, bearing, from French geste, from Old French, from Latin gestus; see ; Ruti Alon, General Partner, Pitango Venture Capital; and Timothy Haines, Partner, Abingworth Management Ltd. The "State of the Medical Device Industry Address" by Medtech Insight/Windhover's Device Editorial Team will take place with speakers to include David Cassak, Managing Director, Windhover Information; Stephen Levin, Executive Editor, FDC FDC - Floppy Disk Controller Windhover; and Tom Salemi, Staff Writer, IN VIVO, STARTUP will begin on April 30th. The second interactive panel discussion will be held on Thursday morning, April 30th, titled "Best Practices and Lessons from the Front Lines: CEOs Talk about Building Successful Companies in Europe Today," with panelists to include Kevin Sidow, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Moximed; Tor Peters, Executive Chairman, Occlutech AB; and Lawrence Kinet, Group CEO, LMA LMA left mentoanterior (position of fetus). International. Regularly updated event details are posted on the In3 Europe website, at www.windhover.com/in3europe09. In3 Europe sponsors include AdvaMed, Life Science Intelligence, MDMA MDMA 3,4-methylenedioxymethamphetamine. MDMA n. 3,4-Methylenedioxymethamphetamine; a mescaline analog. MDMA 3,4 methylenedioxy-methamphetamine. See Ecstasy. , MTB MTB Mountain Bike MTB Mycobacterium Tuberculosis MTB Marshall Tucker Band MTB Motor Torpedo Boat MTB Making The Band (TV show) MTB Minus The Bear (band) MTB Mozilla Thunderbird Europe, Ronald Trahan Associates, and FDC Reports' The Gray Sheet. Medtech Insight and its parent company, Windhover Conferences, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1600 emerging medical technology company presenters and over 8000 attendees have participated at In3 events over the past 8 years. The In3 Europe registration fee is $1795, with additional discounts available when registering multiple attendees. Visit www.windhover.com/in3europe09 to register for this special event. Medtech Insight and Windhover Conferences will also hold the upcoming "Investment In Innovation (In3) East" and "Medical Device Investor Day" being held prior to "Investment In Innovation (In3) East" conference at The Westin Copley Place in Boston, MA, June 23-25, 2009. For more information on these investment and partnering events, please contact Medtech Insight. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion